Technology Improvements Drive Capacity Gains for Biologics Fill/Finish
In-house biologics fill/finish operations have invested in new technologies and have available capacity while small-molecule fill-finish facilities work at near-capacity on legacy equipment.
New Excipient Options for Oral Solid Dosage Drugs
Experts review considerations for selecting excipients for solid-dosage drug performance and manufacturability.
Extending Shelf Life through Better Blister Package Designs
Better barrier materials and software modeling streamline the blister-package design process.
More Growth Expected for API Custom Manufacturing in 2015
Custom API manufacturers firms that offer specialized capabilities will benefit from the continuing trend toward pharmaceutical outsourcing.
Catalent Expands High-Potency Handling Capability
Catalent will add potent containment for blending and granulation at its New Jersey manufacturing Center of Excellence.
PPD Announces Completion of Clinical Studies Facility in Ireland
PPD announced that it completed an expansion to its Athlone, Ireland facility, resulting in 20,000-square-feet of dedicated space for warehousing and distribution purposes.
Ash Stevens to Manufacture Amotosalen API
FDA has approved the Ash Steven’s manufacturing facility in Riverview, MI for the manufacture of Amotosalen.
SAFC Expands Irvine Facility
The new facility will feature dry powder cell-culture media capabilities.
FUJIFILM Diosynth Begins Work on Bioprocess Innovation Center
The new facility will feature new research and development capabilities.
AMRI Acquires Two Aptuit Facilities
The acquisition of Aptuit's Glasgow, UK and Indiana, US facilities will add sterile injectable formulation development and expand AMRI's analytical services capabilities.
